• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Antidotes
    9 Drugs classified under this biological system


    All the biological system drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Atropine Sulphate S.A.L.F 1mg/ml
    Raz Pharmaceutics
    RX
    not in the basket chart
    Atropine Sulphate S.A.L.F 1mg/ml

    Anticholinergic agent. Atropine Sulphate 1 mg/ml.
    AMP. (sol. for IM, IV inj.): 5×1ml. Pre-anesthet. med.: Adults: 0.3-0.6 mg by IV inj. immed. before the anesthes. induct. or by IM inj. 30-60 min. before the induc.
    Child.: 0.02 mg/kg (max. dose 0.6 mg).
    Tmt. of sinus bradycard.: 0.3 and 1.0 mg IV.
    Antidote in poison. by organophosphorus:
    Adult.: 2 mg (IM or IV, taking into account the sever. of the poison.) every 5-10 min., until the skin becomes red and dry, the pupils dilate and tachycard. appears.
    Child.: The 0.02 mg/kg.
    Preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. Treatment of sinus bradycardia, particularly if complicated by hypotension.
    Antidote in poisoning by organophosphorus.
    C/I: Hypersens. Clos. ang. glauc., esophag. reflux, pyloric stenosis, GI obstruct., ulcerat. colit., prostat. hypertrophy, paralytic ileus, intest. atony.

    Calciumfolinat “Ebewe” 10 mg/ml
    Novartis
    RX
    not in the basket chart
    Calciumfolinat “Ebewe” 10 mg/ml

    Alkylating Agent. Calcium Folinate 10 mg/ml.
    VIALS (sol. for inj.): 1 x 100 mg/10 ml, 200 mg/20 ml, 500 mg/50 ml, 1000 mg/100 ml.
    I.V./I.M. only. If use I.V: No more than
    160 mg/min, diluted with 0.9% sod.
    chlor. sol. or 5% glucose sol. See lit.
    To diminish the toxic. and counteract the
    action of folic acid antagonists in
    cytotoxic ther. As Leucovorin-Fluorouracil
    chemotherapy comb. for cancer tmt.
    C/I: Hypersens., pernicious anem., other
    anem. due to B12 defic.

    Desferal® 0.5 g
    Novartis
    RX
    full basket chart
    Desferal® 0.5 g

    Chelating Agent. Deferoxamine Mesylate 0.5 g.
    VIALS: 10 x 500 mg. I.M. inject., I.V./S.C.
    infus: 20-60 mg dly. See lit.
    Chronic iron overload; acute iron
    poisoning; diagn. test for iron overload,
    chron. alumin. overload in renal fail. in
    maint. dialysis, aluminum-related bone
    dis., dialysis enceph., anem. Diagnosis iron
    overload.
    C/I: Hypersens., pregn., lact.

    Epipen
    Trupharm
    RX
    partial basket chart
    Epipen

    Sympathomimetic. Epinephrine 0.3 mg /0.3 ml.
    AUTO-INJECTOR: (for intramusc. use for
    immediate self-admin.) Single units.
    Delivers a single dose of 0.3 mg for
    adults and child over 30 kg.
    Severe allerg. react. (anaphylaxis) to
    hymenoptera stings, foods and other
    allergens and in life threatening
    situations
    caused by asth. attack.
    C/I: See lit. (In life-threat. sit. no
    absolute C.I.).

    Epipen Junior
    Trupharm
    RX
    partial basket chart
    Epipen Junior

    Sympathomimetic. Epinephrine 0.15 mg / 0.3 ml.
    AUTO-INJECTOR: (for intramusc. use for
    self-admin.) Single unit. Delivers a
    single dose of 0.15 mg as support. ther.
    Child (over 15 kg): 0.01 mg/kg bdy. wt.
    Severe allerg. react. (anaphylaxis) to
    hymenoptera stings, foods and other
    allergens and in life threat. situations
    caused by asth. attack.
    C/I: See lit. (In life-threat. sit. no absolute
    C.I.).

    Exjade
    Novartis
    RX
    partial basket chart
    Exjade

    Iron Chelating Agent. Deferasirox 125, 250, 500 mg.
    DISPERS. TABS: 28. See lit.
    Tmt. of chronic iron overload due to blood
    transfuse. in adult & pediat. pts. (2 yrs and
    over). Tmt. of chronic iron overload in pts.
    with non-transfus.-depend. thalassemia
    syndr. aged 10 yrs and older. Chelation ther.
    should only be init. when there is evidence of iron overload (liver iron concentration [LIC] 5 mg Fe/g [dw] or serum ferritin consist. >800 g/l). LIC is the pref. method of iron overload determin. and should be used wherever available.
    C/I: Hypersens. to the product. High risk
    myelodysplastic syndrome pts. and pts.
    with other hematology. and nonhematolog.
    malign. who are not
    expected to benefit from chelation ther.
    due to the rapid progress. of their
    disease. CLcr < 60 mL/min or serum cr >2
    times the age-appropr. ULN. PLT counts
    <50 x 109/L.

    CLOSE